Flagship Pioneering and Quotient Therapeutics partner with Pfizer to discover new therapeutic targets for cardiovascular and renal diseases. They will analyze somatic mutations in diseased tissue to develop innovative treatments.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing